Qdot™ 625 Streptavidin Conjugate
Qdot™ 625 Streptavidin Conjugate
Invitrogen™

Qdot™ 625 Streptavidin Conjugate

Qdot™ 625 streptavidin Conjugate는 형광라벨(Qdot™ nanocrystal)에 공유결합된 비오틴 결합 단백질(streptavidin)로 이루어집니다. Streptavidin은 비오틴 결합 친화력이 매우 높고, streptavidin conjugate는 보통자세히 알아보기
Have Questions?
보기 방식 변경buttonViewtableView
카탈로그 번호수량
Q2206350 μL
A10196200 μL
카탈로그 번호 Q22063
제품 가격(KRW)
283,000
온라인 행사
Ends: 31-Dec-2025
353,000
할인액 70,000 (20%)
Each
카트에 추가하기
수량:
50 μL
제품 가격(KRW)
283,000
온라인 행사
Ends: 31-Dec-2025
353,000
할인액 70,000 (20%)
Each
카트에 추가하기
Qdot™ 625 streptavidin Conjugate는 형광라벨(Qdot™ nanocrystal)에 공유결합된 비오틴 결합 단백질(streptavidin)로 이루어집니다. Streptavidin은 비오틴 결합 친화력이 매우 높고, streptavidin conjugate는 보통 biotin conjugate와 함께 사용되어 다양한 단백질, 단백질 모티프, 핵산, 기타 분자를 특이적으로 검출합니다(예: 단백질 표적에 결합한 biotinylated 일차 항체를 형광 표지된 streptavidin으로 검출할 수 있습니다.). 이와 유사한 전략이 western blot, 유세포분석 (flow cytometry), 영상 및 현미경 분석, 마이크로플레이트 분석 등 많은 검출 protocol에 사용되며 목표한 분획을 달성하기 위한 정제 workflow에도 사용됩니다. Qdot™ nanocrystal conjugate는 1 μM 용액으로 제공됩니다.

Qdot™ Streptavidin Conjugate의 주요 특징:
• Streptavidin Qdot™ 625 conjugate 최대 emission: ∼625 nm
• Qdot™ nanocrystal 당 streptavidins 약 5∼10개
• 탁월한 광안정성 및 밝은 형광
• single-line 여기원으로 효율적으로 여기
• 좁은 emission 구역, 넓은 스톡스 이동(Stokes shift)
• 여러 색으로 이용 가능
• western blot, 유세포분석 (flow cytometry), 영상 및 현미경분석, 마이크로플레이트 분석 등에 적합

Qdot™ Nanocrystal의 특징
Qdot™ streptavidin conjugate는 큰 거대분자 또는 단백질(∼15–20 nm) 크기로 가장 밝은 범주의 검출 시약입니다. Qdot™ streptavidin conjugate는 semiconductor material의 나노미터 크기 결정(CdSe)으로 만들어지며 추가 semiconductor shell (ZnS)로 코팅되어 물질의 광학적 속성을 향상시킵니다. Qdot™ 705 과 Qdot™ 800 streptavidin conjugate는 CdSeTe를 함유하며, 유사한 방식으로 만들어집니다. 이 core-shell 물질은 polymer shell로 추가적으로 코팅되어 있어 물질이 생체 분자에 접합하고 광학적 속성을 유지할 수 있습니다.

다른 streptavidin 형광 conjugate도 구매할 수 있습니다.
다양한 여러 Qdot™ 색상을 제공해드리고 있습니다. 6가지 색상의 Qdot™ streptavidin conjugate 525, 565, 585, 605, 655, 705가 포함된 Qdot™ Streptavidin Sampler Kit를 이용해 보세요. Nanocrystal conjugate 외에 본사에서는 Alexa Fluor™ dyes, Oregon Green™ dye, enzyme conjugates, 및 Texas Red™ dye, fluorescein (FITC) 등의 기존 flurophore에 접합된 다양한 streptavidin을 제공합니다.

Biotinylated Conjugate 찾기
본사는 biotin-streptavidin 검출 전략에 사용되는 다양한 biotinylated conjugate를 제공합니다.
일차 항체 검색 도구를 사용하여 biotinylated 일차 항체를 찾아보세요.
이차 항체 검색 도구를 사용해 biotinylated 이차 항체와 biotinylated anti-dye, anti-hapten 항체를 찾아볼 수 있습니다.

내인성 biotin 차단
자연 발생 biotin은 biotin-streptavidin 검출에 지장을 줄 수 있습니다. 고정세포 및 투과세포를 사용하는 실험에는 자사의 Endogenous Biotin-Blocking Kit를 사용하여 방해요인을 최소화하세요.

관련 링크:
Avidin-Biotin 검출에 대해 더 알아보기
Qdot™ Nanocrystals에 대해 더 알아보기
For Research Use Only. Not for use in diagnostic procedures.
사양
농도1 μM
제품 유형Streptavidin Conjugate (fluorescent)
수량50 μL
배송 조건Room Temperature
형태Liquid
제품라인Qdot, VIVID
Unit SizeEach
구성 및 보관
1 tube , store at 2 to 6 °C upon reciept.
Do Not Freeze.

자주 묻는 질문(FAQ)

I used a neuron-specific antibody to label my neurons. I can't get enough signal from my fluorescent dye conjugated primary antibody. What can I do to improve it?

Here are our recommendations:

Use one of our extensive selection of secondary antibodies conjugated to bright, photostable Alexa Fluor dyes. The degree of labeling for each conjugate is 2-8 fluorophores per IgG molecule, with potentially three secondary antibody-binding sites per primary antibody, providing signal amplification of approximately 10-20 fluorophores per primary antibody.
Alternatively, primary antibody labeling can be detected with a biotinylated secondary antibody in conjunction with either a fluorescent streptavidin or a streptavidin bridge followed by a biotinylated reporter such as Qdot biotin. Although processing times increase with additional incubation and endogenous biotin-blocking steps, detection sensitivity also improves as a result of the labeled streptavidin.
For low-abundance targets, signal amplification may be necessary for optimal signal-to-noise ratios. Tyramide signal amplification (TSA) is an enzyme-mediated detection method that utilizes the catalytic activity of horseradish peroxidase (HRP) to generate reactive fluorophore-labeled tyramide radicals. These short-lived tyramide radicals covalently couple to nearby residues, producing an amplified fluorescent signal localized at the HRP-target interaction site.
For improved detection sensitivity with rapidly bleaching dyes, our SlowFade Diamond or ProLong Diamond antifade reagents have been shown to increase photostability and reduce initial fluorescence quenching in fixed cells, fixed tissues, and cell-free preparations.
Please review this web page for further optimization tips (https://www.thermofisher.com/us/en/home/references/newsletters-and-journals/bioprobes-journal-of-cell-biology-applications/bioprobes-issues-2011/bioprobes-66-october-2011/guide-to-immunocytochemistry.html).

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

I have a very low-abundance antigen. How can I amplify my signal?

A common method for amplifying antibody detection is biotin-streptavidin detection, where a biotinylated secondary antibody is combined with subsequent labeling with a dye-conjugated streptavidin. This will amplify the signal by approximately 2-8 times, but endogenous biotin must be blocked beforehand. Another option is to use tyramide-signal amplification, where a horseradish peroxidase conjugate is used with a dye-labeled tyramide. This will amplify the signal by approximately 10-20 times, but endogenous peroxidase will need to be blocked. A final option may be to use a Qdot nanoparticle antibody or streptavidin conjugate, which can yield a signal as much as 40 times higher than a standard organic dye conjugate, depending on the Qdot color.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

I am getting very high background with my Qdot streptavidin conjugate. Do you have any suggestions?

Here are some suggestions: Use the Qdot Incubation Buffer (Cat. No. Q20001MP). The included buffer is formulated specifically for improved signal-to-background ratios in most immunolabeling applications using the Qdot streptavidin conjugates. Alternate buffers may result in more variable staining and, in particular, may increase background staining. However, some specific applications may require other buffer conditions. Please see the protocol "Double-labeling Using Qdot Streptavidin conjugates."
Determine if the sample has a high level of endogenous biotin. Block the sample using an avidin-biotin pre-blocking step.
If you have used the Qdot Incubation Buffer and still get high nonspecific background, then it may be necessary to check other steps of your procedure. Blocking the sample with BSA or normal animal serum will generally decrease nonspecific binding of both antibodies and Qdot streptavidin conjugates. It is a good practice to dilute your primary and secondary antibodies in the blocking buffer. Some tissues such as spleen and kidney sections may contain endogenous biotin, which may contribute to non-specific signal. Endogenous biotin can be blocked with an avidin/biotin blocking kit (Cat. No. E21390).
Grainy staining or clumps of fluorescent material appear in the background.
Occasionally the BSA within the Qdot Incubation Buffer shows slight aggregation over time. It is necessary to remove this aggregate prior to labeling the sample with the Qdot streptavidin conjugate. Spin down the incubation mixture before addition to the sample. This can be accomplished by spinning the samples in a benchtop centrifuge (Eppendorf 5415) at 5,000 x g for 2 minutes. The material can also be passed over a 0.2 µm spin filter unit before you add it to the sample for staining to remove microscopic precipitates. If you are using a buffer that is different than the Qdot Incubation Buffer, this behavior can often be attributed to higher levels of NaCl or other salts in the incubation buffer, and may not be easily fixed with filtration. In this case, reduce the overall salt concentration.
Optimize concentration of biotinylated secondary antibodies.
Optimizing specific signal can often be achieved by adjusting the level of biotinylated antibody used instaining. High levels of biotinylated antibody are necessary to obtain specific labeling, but overly high levels will contribute to nonspecific binding of the antibody to the sample. Nonspecifically bound biotinylated antibody will bind to the Qdot streptavidin conjugate, resulting in higher staining of the background.
Optimize concentration of Qdot streptavidin conjugate.
Just as titration of primary and secondary antibodies is necessary to achieve optimal specific signal in immunolabeling applications, the level of the final probe should be optimized for each conjugate. In general, concentrations at or slightly below saturation should have the optimal signal-to-background ratio, while concentrations substantially higher than saturation will compromise the assay with higher background levels.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

I am getting no signal with my Qdot streptavidin conjugate. What should I do?

Here are some suggestions:

Confirm imaging/detection setup suitability.
Make sure that you are using an appropriate filter set to detect the signal. Please consult Table 1 in the Qdot Biotin User Manual for a list of appropriate and optimal filters.
Check to see that Qdot conjugate is fluorescing using an alternative light source.
Qdot conjugates will normally fluoresce brightly under a hand-held ultraviolet lamp (long wave, such as the type used to visualize ethidium bromide on agarose gels). Although we have not seen pronounced loss of fluorescence of these materials under any storage conditions that we have investigated, we have not been able to examine all storage conditions. If the Qdot product does not appear to fluoresce under the long wave UV excitation, please contact Technical Support at techsupport@qdots.com. For a microscope, perform a spot test: place a small droplet (2 to 5 µL) of the quantum dot solution onto a clean slide (no coverslip) and examine under the appropriate filter set at low magnification.
Confirm the specificity and titer of primary antibody.
Make sure the antibody will recognize the intended targets. Make sure there is sufficient primary antibody bound to the targets. This verification can be performed by ELISA-based capture of the antigen of interest, or by other techniques that can be found in lab manuals such as the Current Protocols in Immunology.
For Qdot streptavidin conjugates, confirm biotinylation of antibody.
Make sure your antibodies are effectively biotinylated. It may be necessary to independently adjust the concentration of both the primary and secondary antibodies used in the assay to obtain optimal signal and minimal background.
PAP pen ink may quench signal.
Use an alternate method for isolating target areas on the slide. If your protocol requires the use of a PAP pen, we recommend the ImmEdge Hydrophobic Barrier Pen (Cat. No. H-4000) from Vector Labs.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

What is the best way to remove white precipitate from my ITK Qdot nanocrystals?

Spinning your ITK Qdot nanocrystals at approximately 3,000 rpm for 3-5 minutes should remove the white precipitate from the supernatant. Use the supernatant immediately.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

인용 및 참조 문헌 (2)

인용 및 참조 문헌
Abstract
TDAG51 mediates epithelial-to-mesenchymal transition in human proximal tubular epithelium.
Authors:Carlisle RE, Heffernan A, Brimble E, Liu L, Jerome D, Collins CA, Mohammed-Ali Z, Margetts PJ, Austin RC, Dickhout JG,
Journal:Am J Physiol Renal Physiol
PubMed ID:22592641
'Epithelial-to-mesenchymal transition (EMT) contributes to renal fibrosis in chronic kidney disease. Endoplasmic reticulum (ER) stress, a feature of many forms of kidney disease, results from the accumulation of misfolded proteins in the ER and leads to the unfolded protein response (UPR). We hypothesized that ER stress mediates EMT in human ... More
Induction of the unfolded protein response after monocyte to macrophage differentiation augments cell survival in early atherosclerotic lesions.
Authors:Dickhout JG, Lhoták Š, Hilditch BA, Basseri S, Colgan SM, Lynn EG, Carlisle RE, Zhou J, Sood SK, Ingram AJ, Austin RC,
Journal:FASEB J
PubMed ID:20966213
Endoplasmic reticulum (ER) stress causes macrophage cell death within advanced atherosclerotic lesions, thereby contributing to necrotic core formation and increasing the risk of atherothrombotic disease. However, unlike in advanced lesions, the appearance of dead/apoptotic macrophages in early lesions is less prominent. Given that activation of the unfolded protein response (UPR) ... More